| Date Filed | Type | Description |
| 10/03/2023 |
8-K
| Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Ob... |
| 08/09/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/09/2023 |
8-K
| Quarterly results |
| 08/07/2023 |
4
| Hull Hans (Chief Business Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Sold 13,069 shares
@ $20, valued at
$261.4k
Sold 1,800 shares
@ $20, valued at
$36k
Sold 20,050 shares
@ $20.01, valued at
$401.2k
Exercised 1,800 options to buy
@ $2.08, valued at
$3.7k
Exercised 8,791 options to buy
@ $2.08, valued at
$18.3k
|
|
| 08/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/18/2023 |
4
| Ouimette Mike (General Counsel & Corp. Sec'y) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 27,187 shares
@ $0 |
|
| 07/18/2023 |
4
| Lefebvre Eric (Chief Medical Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 43,750 shares
@ $0 |
|
| 07/18/2023 |
4
| Hull Hans (Chief Business Officer) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 35,156 shares
@ $0 |
|
| 07/18/2023 |
4
| Cummings Keith Lamont (CFO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 38,750 shares
@ $0 |
|
| 07/18/2023 |
4
| Coulie Bernard (President and CEO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 137,500 shares
@ $0 |
|
| 06/12/2023 |
4
| Cummings Keith Lamont (CFO) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Exercised 5,800 options to buy
@ $2.08, valued at
$12.1k
|
|
| 06/08/2023 |
4
| Shah Smital (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $23.09, valued at
$323.3k
|
|
| 06/08/2023 |
4
| PYOTT DAVID E I (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $23.09, valued at
$323.3k
|
|
| 06/08/2023 |
4
| MCCOURT Thomas A (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $23.09, valued at
$323.3k
|
|
| 06/08/2023 |
4
| Knobil Katharine (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $23.09, valued at
$323.3k
|
|
| 06/08/2023 |
4
| Huh Hoyoung (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $23.09, valued at
$323.3k
|
|
| 06/08/2023 |
4
| Curnutte John T (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $23.09, valued at
$323.3k
|
|
| 06/08/2023 |
4
| CROWELL GAYLE A (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $23.09, valued at
$323.3k
|
|
| 06/08/2023 |
4
| Cline Darren S (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $23.09, valued at
$323.3k
|
|
| 06/08/2023 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $23.09, valued at
$323.3k
|
|
| 06/08/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/09/2023 |
8-K
| Quarterly results |
| 05/01/2023 |
8-K
| Quarterly results |
| 04/27/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/26/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/03/2023 |
4
| Ouimette Mike (General Counsel & Corp. Sec'y) has filed a Form 4 on PLIANT THERAPEUTICS, INC.|
Txns:
| Sold 4,874 shares
@ $26.5209, valued at
$129.3k
Sold 2,677 shares
@ $26.7371, valued at
$71.6k
Sold 200 shares
@ $27.455, valued at
$5.5k
|
|
|